While GPT-5.2 is the latest update from OpenAI, executives from the firm said that it would be incorrect to view the latest ...

Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who are ...

Cirrus remains a vision investment with lots of somewhat fuzzy growth opportunities coming, even strong possibilities for ...

EV manufacturer Rivian, a key partner of Volkswagen, unveiled its own in-house developed silicon chip at its first 'Autonomy ...

A global memory chip shortage, driven by insatiable AI data center demand, is skyrocketing prices for everyday electronics.

CES 2026 will feature press conferences from companies like Samsung and AMD, and new breakthroughs in robotics and AI.

Researchers at the University of Geneva, together with colleagues in Switzerland, France, the United States and Israel, ...

Barclays 23rd Annual Global Technology Conference December 11, 2025 2:35 PM ESTCompany ParticipantsRukmini Sivaraman - ...

UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing* First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and anti-MuSK ...

EssilorLuxottica has announced plans to acquire Signifeye, a leading Belgian ophthalmology platform operating 15 clinics across the Flanders region, further expanding its presence in specialized eye ...